Literature DB >> 21699897

Delayed induction, not impaired recruitment, of specific CD8⁺ T cells causes the late onset of acute hepatitis C.

Eui-Cheol Shin1, Su-Hyung Park, Mary Demino, Michelina Nascimbeni, Kathleen Mihalik, Marian Major, Naga S Veerapu, Theo Heller, Stephen M Feinstone, Charles M Rice, Barbara Rehermann.   

Abstract

BACKGROUND & AIMS: Hepatitis C virus (HCV) infection is characterized by lack of immune-mediated liver injury despite a high level of HCV replication during the incubation phase, which lasts about 8 weeks. We investigated whether this results from delayed recruitment of HCV-specific T cells and whether it facilitates HCV persistence.
METHODS: Six chimpanzees were infected with HCV; blood and liver samples were collected for 28 weeks and analyzed for immune cells and chemokines.
RESULTS: Two chimpanzees developed self-limited infections, whereas the remaining 4 developed chronic infections. Levels of the chemokines CXCL10, CXCL11, CCL4, and CCL5 increased in blood and liver samples from all chimpanzees within 1 month of HCV infection. Chemokine induction correlated with intrahepatic type I interferon (IFN) responses in vivo and was blocked by neutralizing antibodies against IFN-β in vitro. Despite the early-stage induction of chemokines, the intrahepatic lymphocytic infiltrate started to increase no earlier than 8 weeks after HCV infection, when HCV-specific, tetramer-positive CD8(+) T cells appeared in the circulation. The HCV-specific CD8(+) T cells expressed chemokine receptors when they were initially detected in blood samples, so they could be recruited to the liver as soon as they entered the circulation.
CONCLUSIONS: Chemokines are induced during early stages of HCV infection, which requires a type I IFN-mediated response. The delayed onset of acute hepatitis does not result from delayed recruitment of HCV-specific T cells, but could instead be related to a primary delay in the induction of HCV-specific T cells. Divergent outcomes occur without evident differences in chemokine induction and T-cell recruitment.
Copyright © 2011 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21699897      PMCID: PMC3359650          DOI: 10.1053/j.gastro.2011.05.006

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  29 in total

1.  Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA.

Authors:  A A Kolykhalov; E V Agapov; K J Blight; K Mihalik; S M Feinstone; C M Rice
Journal:  Science       Date:  1997-07-25       Impact factor: 47.728

2.  Hepatitis C virus kinetics and host responses associated with disease and outcome of infection in chimpanzees.

Authors:  Marian E Major; Harel Dahari; Kathleen Mihalik; Montserrat Puig; Charles M Rice; Avidan U Neumann; Stephen M Feinstone
Journal:  Hepatology       Date:  2004-06       Impact factor: 17.425

3.  Plasmacytoid dendritic cells sense hepatitis C virus-infected cells, produce interferon, and inhibit infection.

Authors:  Ken Takahashi; Shinichi Asabe; Stefan Wieland; Urtzi Garaigorta; Pablo Gastaminza; Masanori Isogawa; Francis V Chisari
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-15       Impact factor: 11.205

4.  Virus-induced type I IFN stimulates generation of immunoproteasomes at the site of infection.

Authors:  Eui-Cheol Shin; Ulrike Seifert; Takanobu Kato; Charles M Rice; Stephen M Feinstone; Peter-M Kloetzel; Barbara Rehermann
Journal:  J Clin Invest       Date:  2006-10-12       Impact factor: 14.808

5.  Identification of novel chimpanzee MHC class I and II alleles using an improved sequence-based typing strategy.

Authors:  Laura Caggiari; Maria Paola Simula; Alessandra Marzotto; Masaaki Shiina; Barbara Rehermann; Valli De Re
Journal:  Hum Immunol       Date:  2006-03-30       Impact factor: 2.850

6.  The kinetics of hepatitis C virus-specific CD8 T-cell responses in the blood mirror those in the liver in acute hepatitis C virus infection.

Authors:  Eui-Cheol Shin; Stefania Capone; Riccardo Cortese; Stefano Colloca; Alfredo Nicosia; Antonella Folgori; Barbara Rehermann
Journal:  J Virol       Date:  2008-07-30       Impact factor: 5.103

7.  Innate immunity defines the capacity of antiviral T cells to limit persistent infection.

Authors:  Daniel M Andrews; Marie J Estcourt; Christopher E Andoniou; Matthew E Wikstrom; Andrea Khong; Valentina Voigt; Peter Fleming; Hyacinth Tabarias; Geoffrey R Hill; Robbert G van der Most; Anthony A Scalzo; Mark J Smyth; Mariapia A Degli-Esposti
Journal:  J Exp Med       Date:  2010-05-31       Impact factor: 14.307

8.  Genomic analysis of the host response to hepatitis B virus infection.

Authors:  Stefan Wieland; Robert Thimme; Robert H Purcell; Francis V Chisari
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-20       Impact factor: 11.205

9.  Proteasome activator and antigen-processing aminopeptidases are regulated by virus-induced type I interferon in the hepatitis C virus-infected liver.

Authors:  Eui-Cheol Shin; Ulrike Seifert; Sabrina Urban; Kim-Thuy Truong; Stephen M Feinstone; Charles M Rice; Peter-M Kloetzel; Barbara Rehermann
Journal:  J Interferon Cytokine Res       Date:  2007-12       Impact factor: 2.607

10.  Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes.

Authors:  F Sallusto; D Lenig; C R Mackay; A Lanzavecchia
Journal:  J Exp Med       Date:  1998-03-16       Impact factor: 14.307

View more
  28 in total

Review 1.  Pathogenesis of chronic viral hepatitis: differential roles of T cells and NK cells.

Authors:  Barbara Rehermann
Journal:  Nat Med       Date:  2013-07       Impact factor: 53.440

2.  Occupational exposure to hepatitis C virus: early T-cell responses in the absence of seroconversion in a longitudinal cohort study.

Authors:  Theo Heller; Jens Martin Werner; Fareed Rahman; Eishiro Mizukoshi; Yuji Sobao; Ann Marie Gordon; Arlene Sheets; Averell H Sherker; Ellen Kessler; Kathleen S Bean; Steven K Herrine; M'lou Stevens; James Schmitt; Barbara Rehermann
Journal:  J Infect Dis       Date:  2013-06-24       Impact factor: 5.226

Review 3.  Insights From Antiviral Therapy Into Immune Responses to Hepatitis B and C Virus Infection.

Authors:  Barbara Rehermann; Robert Thimme
Journal:  Gastroenterology       Date:  2018-09-26       Impact factor: 22.682

4.  The Balance between CD8+ T Cell-Mediated Clearance of AAV-Encoded Antigen in the Liver and Tolerance Is Dependent on the Vector Dose.

Authors:  Sandeep R P Kumar; Brad E Hoffman; Cox Terhorst; Ype P de Jong; Roland W Herzog
Journal:  Mol Ther       Date:  2017-03-09       Impact factor: 11.454

5.  IL-29 is the dominant type III interferon produced by hepatocytes during acute hepatitis C virus infection.

Authors:  Heiyoung Park; Elisavet Serti; Onyinyechi Eke; Brian Muchmore; Ludmila Prokunina-Olsson; Stefania Capone; Antonella Folgori; Barbara Rehermann
Journal:  Hepatology       Date:  2012-11-19       Impact factor: 17.425

6.  Successful vaccination induces multifunctional memory T-cell precursors associated with early control of hepatitis C virus.

Authors:  Su-Hyung Park; Eui-Cheol Shin; Stefania Capone; Laura Caggiari; Valli De Re; Alfredo Nicosia; Antonella Folgori; Barbara Rehermann
Journal:  Gastroenterology       Date:  2012-06-13       Impact factor: 22.682

Review 7.  T Lymphocytes as Measurable Targets of Protection and Vaccination Against Viral Disorders.

Authors:  Anne Monette; Andrew J Mouland
Journal:  Int Rev Cell Mol Biol       Date:  2018-10-24       Impact factor: 6.813

Review 8.  T cell responses in hepatitis C virus infection: historical overview and goals for future research.

Authors:  Lauren Holz; Barbara Rehermann
Journal:  Antiviral Res       Date:  2014-11-26       Impact factor: 5.970

9.  The frequency of CD127(+) hepatitis C virus (HCV)-specific T cells but not the expression of exhaustion markers predicts the outcome of acute HCV infection.

Authors:  Eui-Cheol Shin; Su-Hyung Park; Michelina Nascimbeni; Marian Major; Laura Caggiari; Valli de Re; Stephen M Feinstone; Charles M Rice; Barbara Rehermann
Journal:  J Virol       Date:  2013-02-06       Impact factor: 5.103

Review 10.  Immune responses and immunopathology in acute and chronic viral hepatitis.

Authors:  Eui-Cheol Shin; Pil Soo Sung; Su-Hyung Park
Journal:  Nat Rev Immunol       Date:  2016-07-04       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.